Holen Sie sich die Stockscreener-App
3.23
1.25%
0.04
Handel nachbörslich:
3.30
0.07
+2.17%
Anixa Biosciences Inc Aktie (ANIX) Neueste Nachrichten
Millennium Management LLC Acquires Shares of 11,028 Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 - Kilgore News Herald
Everything You Need to Know About the New Breast Cancer Vaccine - Vogue
Bank of America Corp DE Sells 6,891 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World
3 Promising Penny Stocks With Market Caps Over $100M - simplywall.st
Anixa Biosciences’ (ANIX) Buy Rating Reaffirmed at D. Boral Capital - Defense World
What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage - GuruFocus
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage | ANIX Stock News - GuruFocus
Anixa Biosciences (ANIX) Maintains 'Buy' Rating with $10 Price T - GuruFocus
Anixa Biosciences (ANIX) Maintains 'Buy' Rating with $10 Price Target | ANIX Stock News - GuruFocus
Revolutionary Breast Cancer Prevention Vaccine Gets Major Media Spotlight: How It Could Eradicate Cancer - Stock Titan
Anixa Biosciences (ANIX) to Present at ESMO Gynaecological Cance - GuruFocus
Anixa Biosciences Announces Poster Presentation on Ovarian Cance - GuruFocus
Anixa Biosciences Announces Poster Presentation On Ovarian Cancer CAR-T Clinical Trial At ESMO Gynaecological Cancers Congress 2025 - MarketScreener
Breakthrough CAR-T Therapy for Ovarian Cancer: Anixa's Phase 1 Trial Results Coming at ESMO 2025 - Stock Titan
Jane Street Group LLC Purchases New Shares in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World
Anixa Biosciences (NASDAQ:ANIX) Upgraded by Wall Street Zen to Hold Rating - Defense World
All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy - MSN
Kalkine Lists top companies in the nasdaq Featuring Innovative Biotech Like Anixa Biosciences - Kalkine Media
FY2025 EPS Forecast for Anixa Biosciences Boosted by Analyst - Defense World
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc with Rec - GuruFocus
Anixa Biosciences CEO Amit Kumar acquires $28,500 in stock - Investing.com Australia
Anixa Biosciences CEO Amit Kumar acquires $28,500 in stock By Investing.com - Investing.com Canada
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? - Yahoo Finance
H.C. Wainwright maintains Buy rating on Anixa Biosciences stock By Investing.com - Investing.com UK
Northern Trust Corp Trims Stock Position in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World
Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview - GuruFocus
Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview | ANIX Stock News - GuruFocus
Revolutionary Breast Cancer Prevention Vaccine Hits Major Milestone: Phase 1 Trial Fully Enrolled - Stock Titan
Anixa Biosciences (ANIX) Concludes Enrollment for Breast Cancer Vaccine Trial | ANIX Stock News - GuruFocus
Anixa Biosciences Announces Completion Of Enrollment In Phase 1 Trial Of Breast Cancer Vaccine - MarketScreener
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine - GuruFocus
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine | ANIX Stock News - GuruFocus
Revolutionary Breast Cancer Vaccine Achieves Major Milestone: 70% of Patients Show Promising Immune Response - Stock Titan
ANIXA BIOSCIENCES Earnings Preview: Recent $ANIX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 - marketscreener.com
Anixa Biosciences’ (ANIX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Anixa Biosciences (ANIX) Retains 'Buy' Rating with $10 Price Tar - GuruFocus
Anixa Biosciences (ANIX) Retains 'Buy' Rating with $10 Price Target | ANIX Stock News - GuruFocus
Anixa Biosciences Inc SEC 10-Q Report - TradingView
Anixa Biosciences (ANIX) Expected to Announce Earnings on Tuesday - Defense World
Anixa Biosciences CEO Provides Letter to Shareholders Outlining - GuruFocus
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones - Nasdaq
Breakthrough: Anixa's Cancer Vaccine Shows 70% Response Rate While CAR-T Therapy Extends Patient Survival - Stock Titan
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - Stock Titan
Renaissance Technologies LLC Has $34,000 Stock Holdings in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World
ANIXAnixa Biosciences Inc Latest Stock News & Market Updates - Stock Titan
Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares Acquired by LPL Financial LLC - Defense World
0.68%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):